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ABSTRACT
We report a case of everolimus-eluting stent restenosis caused 
by neoatherogenesis. Optical coherence tomography indicated 
the presence of a superficial arch with high optical intensity in 
the in-stent mid-segment, followed by significant signal attenu-
ation, with poorly defined borders, indicating the presence of 
lipid infiltration and/or necrotic core, similar to that observed 
in de novo coronary lesions. Signs suggesting macrophage/ 
foam cell infiltration were observed inside the fibrous cap, 
indicating the presence of local inflammatory activity. The 
development of new in-stent atherosclerosis at the site of a 
pre-existing neointimal tissue (neoatherosclerosis) was recently 
identified as an additional cause of coronary stent failure. 
The present report is one of the first to demonstrate the find-
ing of neoatherosclerosis as a second generation drugeluting 
stent failure.
 
 
 
 
DESCRIPTORS: Coronary artery disease. Coronary restenosis. 
Angioplasty. Drug-eluting stents.
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Case Report
RESumO
Neoaterosclerose Precoce como Causa de Reestenose 
de Stent Farmacológico de Segunda Geração
Relatamos um caso de reestenose de stent eluidor de everolimus 
causada por neoaterogênese. A tomografia de coerência óptica 
revelou, no segmento médio intrastent, presença de arco superficial 
com alta intensidade óptica, seguido por significativa atenuação 
do sinal luminoso, com limites mal definidos, indicando pre-
sença de infiltração lipídica e/ou núcleo necrótico, semelhante 
ao observado em lesões coronárias de novo. Sinais sugerindo 
infiltração de macrófagos/foam cells puderam ser observados no 
interior da capa fibrosa, denotando presença de atividade infla-
matória local. O surgimento de nova aterosclerose intrastent, no 
local de um tecido neointimal já formado (neoaterosclerose), tem 
sido recentemente identificado como causa adicional de falência 
de stents coronários. O presente relato é um dos primeiros a 
demonstrar o achado de neoaterosclerose como falha de um 
stent farmacológico de segunda geração.
DESCRITORES: Doença da artéria coronariana. Reestenose 
coronária. Angioplastia. Stents farmacológicos.
T he case of a 58-year-old male patient is reported, an ex-smoker, with hypertension and prior coro-nary artery bypass grafting surgery, who presented 
with acute myocardial infarction without ST-segment 
elevation on January 1, 2012, and was submitted to 
percutaneous coronary intervention on January 18, 2012, 
with implantation of an everolimus-eluting stent in the 
middle third of the left circumflex artery.
Six months after the procedure, the patient returned 
complaining of stable angina class II according to the 
classification of the Canadian Cardiovascular Society (CCS).
A new angiography showed focal in-stent reste-
nosis (Figure 1). An optical coherence tomography 
was performed (Figures 2 and 3) and demonstrated a 
heterogeneous vascular response pattern throughout the 
previously treated segment. The distal segment of the 
stent had a satisfactory vascular healing pattern, with a 
thin layer of neointimal hyperplasia with circumferential 
distribution and regular borders, in which the tissue 
had a homogeneous pattern of high optical intensity1 
(Figure 2, panel 1). In contrast, the proximal intrastent 
segment showed more pronounced neointimal suppres-
sion, with the heterogeneous distribution of a fine layer 
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Figure 1 – Coronary angiography of the procedure and at 6 months. In A, angiography shows an eccentric lesion in the middle third of the left cir-
cumflex artery. The arrow points to the stenosis. In B, the final angiographic result after implantation of an everolimus-eluting stent of 3.5 x 23 mm, 
post-dilated with a non-compliant balloon of 4  x  12  mm up to 16  atm. A satisfactory angiographic result without residual stenosis in the in-stent 
segment, no signs of injury at the borders and preserved distal epicardial flow (Thrombolysis In Myocardial Infarction – TIMI 3) were observed. Yellow 
arrows delimit the stent borders. In C, coronary angiography six months after the procedure with binary angiographic restenosis (stenosis diameter of 
62%), focal, restricted to the in-stent segment is shown. Yellow arrows delimit the stent borders, and the green arrow points to the site of restenosis. 
Figure 2 – Optical coherence tomography. In the top panel, longitudinal reconstruction of the left circumflex artery. The stent limits are iden-
tified by the yellow vertical bars. The white dotted vertical bars identify three representative images of the intrastent distal segment, site of 
restenosis and intrastent proximal segment corresponding to images of cross-sections of the vessel shown in the lower panel. Bottom Panel 1: 
distal segment of the stent showing a region with normal neointimal hyperplasia characterized by homogeneous circumferential distribution, 
a regular outline and high optical intensity. Bottom Panel 2: site of restenosis with eccentric distribution of neointimal tissue that has charac-
teristics similar to those of a lipid plaque in de novo lesions. The white dots indicate the position of the stent struts that were not visualized 
due to important attenuation of the optical signal. The yellow arrows indicate areas of increased superficial brightness within the fibrous cap, 
suggesting the infiltration of macrophages/foam cells. Bottom Panel 3: proximal stent segment showing heterogeneous vascular healing with 
the presence of struts not covered by neointimal tissue (arrows).
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stents.4-6 A series of 299 autopsy cases demonstrated 
that the incidence of neoatherosclerosis is greater in 
lesions treated with first-generation drug-eluting stents 
(DES; 31%) compared with bare-metal stents (BMS; 16%), 
and the time to its onset is shorter after implantation 
of a DES (420 days – 361 days to 683 days) when 
compared to BMS (2,160 days – 1,800 days to 2,880 
days).7 To date, descriptions of encountering neoathe r -
osclerosis in second-generation DES are scarce. The 
present report is one of the first to report the finding of 
neoatherosclerosis as a second-generation stent failure. 
The prematurity of this phenomenon is noteworthy and 
deserves further investigation.
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of neointimal tissue and presence of several struts with 
no tissue covering them (Figure 2, panel 3).
In the medium intrastent segment (Figure 2, panel 
2), significant neointimal proliferation with expressive 
involvement of the luminal area was observed. A high 
optical intensity shallow arch, followed by significant 
attenuation of the light signal in which boundaries were 
poorly defined was observed, suggesting the existence 
of fatty infiltration and/or a necrotic core similar to 
de novo coronary lesions,2 showing new intrastent 
atherosclerosis.3 The optical signal attenuation was so 
expressive that it prevented the identification of the 
structure of the metallic stent struts. Signs of local 
inflammatory activity could be inferred by visualising a 
‘flecked’ glow within the fibrous cap, with an optical 
intensity greater than the surrounding fibrous tissue, 
suggesting the infiltration of clusters of macrophages/
foam cells.
In the three-dimensional reconstruction of the optical 
coherence tomography images, there was a discontinuity 
image in the central region of the stent structure (restenosis 
site) resulting from the hyperattenuation of the optical 
signal by the neoatherogenic tissue (Figure 3A).
The development of new intrastent atherosclerosis at 
the site of already formed neointimal tissue (neoathero-
s clerosis) has recently been identified as an additional 
cause of failure (restenosis or thrombosis) of coronary 
Figure 3 – Three-dimensional reconstruction of optical coherence tomography images. In A, three-dimensional reconstruction of the stent revealing 
discontinuity of the stent structure at the site of restenosis through important attenuation of the optical signal promoted by fatty infiltration of the 
neointima. In B, longitudinal images of the open vessel in two orthogonal planes showing the eccentricity and the three-dimensional distribution 
of the restenosis point. The black arrows indicate the site of restenosis. The asterisk indicates the shadow caused by the presence of the 0.014-inch 
guidewire. In C, fly-through visualisation of the coronary vessel showing the spatial distribution of neointimal tissue at the site of restenosis. The 
darker neointimal tissue at the point of restenosis compared with other regions of the vessel is the result of the attenuation of the light signal by 
lipid infiltration. The asterisk indicates the shadow caused by the presence of the guidewire.
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